O	0	3	The	The	DT	B-NP
O	4	13	candidate	candidate	NN	I-NP
B-Cancer	14	20	tumour	tumour	NN	I-NP
O	21	31	suppressor	suppressor	NN	I-NP
O	32	39	protein	protein	NN	I-NP
O	40	44	ING4	ING4	NN	I-NP
O	45	54	regulates	regulate	VBZ	B-VP
B-Cancer	55	60	brain	brain	NN	B-NP
I-Cancer	61	67	tumour	tumour	NN	I-NP
O	68	74	growth	growth	NN	I-NP
O	75	78	and	and	CC	I-NP
O	79	91	angiogenesis	angiogenesis	NN	I-NP
O	91	92	.	.	.	O

B-Cancer	93	100	Gliomas	Glioma	NNS	B-NP
O	101	104	are	be	VBP	B-VP
O	105	108	the	the	DT	B-NP
O	109	113	most	most	RBS	I-NP
O	114	120	common	common	JJ	I-NP
B-Cancer	121	128	primary	primary	JJ	I-NP
I-Cancer	129	136	tumours	tumour	NNS	I-NP
O	137	139	of	of	IN	B-PP
O	140	143	the	the	DT	B-NP
B-Anatomical_system	144	151	central	central	JJ	I-NP
I-Anatomical_system	152	159	nervous	nervous	JJ	I-NP
I-Anatomical_system	160	166	system	system	NN	I-NP
O	166	167	,	,	,	O
O	168	172	with	with	IN	B-PP
O	173	179	nearly	nearly	RB	B-NP
O	180	182	15	15	CD	I-NP
O	182	183	,	,	,	I-NP
O	183	186	000	000	CD	I-NP
O	187	196	diagnosed	diagnose	VBN	B-VP
O	197	205	annually	annually	RB	B-ADVP
O	206	208	in	in	IN	B-PP
O	209	212	the	the	DT	B-NP
O	213	219	United	United	NNP	I-NP
O	220	226	States	State	NNPS	I-NP
O	227	230	and	and	CC	O
O	231	232	a	a	DT	B-NP
O	233	242	lethality	lethality	NN	I-NP
O	243	254	approaching	approach	VBG	B-VP
O	255	257	80	80	CD	B-NP
O	257	258	%	%	NN	I-NP
O	259	265	within	within	IN	B-PP
O	266	269	the	the	DT	B-NP
O	270	275	first	first	JJ	I-NP
O	276	280	year	year	NN	I-NP
O	281	283	of	of	IN	B-PP
B-Cancer	284	296	glioblastoma	glioblastoma	NN	B-NP
O	297	306	diagnosis	diagnosis	NN	I-NP
O	306	307	.	.	.	O

O	308	311	The	The	DT	B-NP
O	312	318	marked	marked	JJ	I-NP
O	319	328	induction	induction	NN	I-NP
O	329	331	of	of	IN	B-PP
O	332	344	angiogenesis	angiogenesis	NN	B-NP
O	345	347	in	in	IN	B-PP
B-Cancer	348	361	glioblastomas	glioblastoma	NNS	B-NP
O	362	370	suggests	suggest	VBZ	B-VP
O	371	375	that	that	IN	B-SBAR
O	376	378	it	it	PRP	B-NP
O	379	381	is	be	VBZ	B-VP
O	382	383	a	a	DT	B-NP
O	384	393	necessary	necessary	JJ	I-NP
O	394	398	part	part	NN	I-NP
O	399	401	of	of	IN	B-PP
O	402	411	malignant	malignant	JJ	B-NP
O	412	423	progression	progression	NN	I-NP
O	423	424	;	;	:	O
O	425	432	however	however	RB	B-ADVP
O	432	433	,	,	,	O
O	434	437	the	the	DT	B-NP
O	438	445	precise	precise	JJ	I-NP
O	446	455	molecular	molecular	JJ	I-NP
O	456	466	mechanisms	mechanism	NNS	I-NP
O	467	477	underlying	underlie	VBG	B-VP
O	478	481	the	the	DT	B-NP
O	482	492	regulation	regulation	NN	I-NP
O	493	495	of	of	IN	B-PP
B-Cancer	496	501	brain	brain	NN	B-NP
I-Cancer	502	508	tumour	tumour	NN	I-NP
O	509	515	growth	growth	NN	I-NP
O	516	519	and	and	CC	I-NP
O	520	532	angiogenesis	angiogenesis	NN	I-NP
O	533	539	remain	remain	VBP	B-VP
O	540	550	unresolved	unresolved	JJ	B-ADJP
O	550	551	.	.	.	O

O	552	556	Here	Here	RB	B-ADVP
O	557	559	we	we	PRP	B-NP
O	560	566	report	report	VBP	B-VP
O	567	571	that	that	IN	B-SBAR
O	572	573	a	a	DT	B-NP
O	574	583	candidate	candidate	NN	I-NP
B-Cancer	584	590	tumour	tumour	NN	I-NP
O	591	601	suppressor	suppressor	NN	I-NP
O	602	606	gene	gene	NN	I-NP
O	606	607	,	,	,	O
O	608	612	ING4	ING4	NN	B-NP
O	612	613	,	,	,	O
O	614	616	is	be	VBZ	B-VP
O	617	625	involved	involve	VBN	I-VP
O	626	628	in	in	IN	B-PP
O	629	639	regulating	regulate	VBG	B-VP
B-Cancer	640	645	brain	brain	NN	B-NP
I-Cancer	646	652	tumour	tumour	NN	I-NP
O	653	659	growth	growth	NN	I-NP
O	660	663	and	and	CC	I-NP
O	664	676	angiogenesis	angiogenesis	NN	I-NP
O	676	677	.	.	.	O

O	678	688	Expression	Expression	NN	B-NP
O	689	691	of	of	IN	B-PP
O	692	696	ING4	ING4	NN	B-NP
O	697	699	is	be	VBZ	B-VP
O	700	713	significantly	significantly	RB	I-VP
O	714	721	reduced	reduce	VBN	I-VP
O	722	724	in	in	IN	B-PP
B-Cancer	725	732	gliomas	glioma	NNS	B-NP
O	733	735	as	as	IN	B-PP
O	736	744	compared	compare	VBN	B-PP
O	745	749	with	with	IN	B-PP
O	750	756	normal	normal	JJ	B-NP
O	757	762	human	human	JJ	I-NP
B-Tissue	763	768	brain	brain	NN	I-NP
I-Tissue	769	775	tissue	tissue	NN	I-NP
O	775	776	,	,	,	O
O	777	780	and	and	CC	O
O	781	784	the	the	DT	B-NP
O	785	791	extent	extent	NN	I-NP
O	792	794	of	of	IN	B-PP
O	795	804	reduction	reduction	NN	B-NP
O	805	815	correlates	correlate	VBZ	B-VP
O	816	820	with	with	IN	B-PP
O	821	824	the	the	DT	B-NP
O	825	836	progression	progression	NN	I-NP
O	837	841	from	from	IN	B-PP
O	842	847	lower	low	JJR	B-ADJP
O	848	850	to	to	TO	B-PP
O	851	857	higher	high	JJR	B-NP
O	858	864	grades	grade	NNS	I-NP
O	865	867	of	of	IN	B-PP
B-Cancer	868	875	tumours	tumour	NNS	B-NP
O	875	876	.	.	.	O

O	877	879	In	In	IN	B-PP
O	880	884	mice	mouse	NNS	B-NP
O	884	885	,	,	,	O
B-Cancer	886	896	xenografts	xenograft	NNS	B-NP
O	897	899	of	of	IN	B-PP
O	900	905	human	human	JJ	B-NP
B-Cancer	906	918	glioblastoma	glioblastoma	NN	I-NP
I-Cancer	919	924	U87MG	U87MG	NN	I-NP
O	924	925	,	,	,	O
O	926	931	which	which	WDT	B-NP
O	932	935	has	have	VBZ	B-VP
O	936	945	decreased	decrease	VBN	I-VP
O	946	956	expression	expression	NN	B-NP
O	957	959	of	of	IN	B-PP
O	960	964	ING4	ING4	NN	B-NP
O	964	965	,	,	,	O
O	966	970	grow	grow	VB	B-VP
O	971	984	significantly	significantly	RB	B-ADJP
O	985	991	faster	fast	JJR	I-ADJP
O	992	995	and	and	CC	O
O	996	1000	have	have	VBP	B-VP
O	1001	1007	higher	high	JJR	B-NP
B-Multi-tissue_structure	1008	1016	vascular	vascular	JJ	I-NP
O	1017	1023	volume	volume	NN	I-NP
O	1024	1033	fractions	fraction	NNS	I-NP
O	1034	1038	than	than	IN	B-PP
O	1039	1046	control	control	NN	B-NP
B-Cancer	1047	1054	tumours	tumour	NNS	I-NP
O	1054	1055	.	.	.	O

O	1056	1058	We	We	PRP	B-NP
O	1059	1063	show	show	VBP	B-VP
O	1064	1068	that	that	IN	B-SBAR
O	1069	1073	ING4	ING4	NN	B-NP
O	1074	1084	physically	physically	RB	B-ADVP
O	1085	1094	interacts	interact	VBZ	B-VP
O	1095	1099	with	with	IN	B-PP
O	1100	1103	p65	p65	NN	B-NP
O	1104	1105	(	(	(	O
O	1105	1109	RelA	RelA	NN	B-NP
O	1109	1110	)	)	)	O
O	1111	1118	subunit	subunit	NN	B-NP
O	1119	1121	of	of	IN	B-PP
O	1122	1129	nuclear	nuclear	JJ	B-NP
O	1130	1136	factor	factor	NN	I-NP
O	1137	1139	NF	NF	NN	I-NP
O	1139	1140	-	-	HYPH	B-NP
O	1140	1146	kappaB	kappaB	NN	I-NP
O	1146	1147	,	,	,	O
O	1148	1151	and	and	CC	O
O	1152	1156	that	that	IN	B-SBAR
O	1157	1161	ING4	ING4	NN	B-NP
O	1162	1171	regulates	regulate	VBZ	B-VP
B-Cancer	1172	1177	brain	brain	NN	B-NP
I-Cancer	1178	1184	tumour	tumour	NN	I-NP
O	1185	1197	angiogenesis	angiogenesis	NN	I-NP
O	1198	1205	through	through	IN	B-PP
O	1206	1221	transcriptional	transcriptional	JJ	B-NP
O	1222	1232	repression	repression	NN	I-NP
O	1233	1235	of	of	IN	B-PP
O	1236	1238	NF	NF	NN	B-NP
O	1238	1239	-	-	HYPH	B-NP
O	1239	1245	kappaB	kappaB	NN	I-NP
O	1245	1246	-	-	HYPH	B-NP
O	1246	1256	responsive	responsive	JJ	I-NP
O	1257	1262	genes	gene	NNS	I-NP
O	1262	1263	.	.	.	O

O	1264	1269	These	These	DT	B-NP
O	1270	1277	results	result	NNS	I-NP
O	1278	1286	indicate	indicate	VBP	B-VP
O	1287	1291	that	that	IN	B-SBAR
O	1292	1296	ING4	ING4	NN	B-NP
O	1297	1300	has	have	VBZ	B-VP
O	1301	1303	an	an	DT	B-NP
O	1304	1313	important	important	JJ	I-NP
O	1314	1318	role	role	NN	I-NP
O	1319	1321	in	in	IN	B-PP
B-Cancer	1322	1327	brain	brain	NN	B-NP
I-Cancer	1328	1334	tumour	tumour	NN	I-NP
O	1335	1347	pathogenesis	pathogenesis	NN	I-NP
O	1347	1348	.	.	.	O

